NEW YORK (GenomeWeb) – Immucor announced Monday that it has received final local coverage determinations for its PreciseType HEA test from Medicare Administrative Contractors (MACs) participating in Palmetto's Molecular Diagnostic Services (MolDX) program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.